Crescent Energy (CRGY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Crescent Energy Company (NYSE:CRGY ) Q4 2024 Earnings Conference Call February 27, 2025 11:00 AM ET Company Participants Reid Gallagher - Investor Relations David Rockecharlie - Chief Executive Officer Brandi Kendall - Chief Financial Officer Clay Rynd - Executive Vice President-Investments Conference Call Participants Oliver Huang - TPH Neal Dingmann - Truist Securities Tim Rezvan - KeyBanc Capital Marketing Michael Scialla - Stephens John Abbott - Wolfe Research Michael Furrow - Pickering Energy John Freeman - Raymond James Operator Ladies and gentlemen, greetings, and welcome to the Crescent Energy Q4 Fiscal Year 2024 Results. At this time, all participants are in a listen-only mode.
Crescent Energy (CRGY) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.58 per share a year ago.
Beyond analysts' top -and-bottom-line estimates for Crescent Energy (CRGY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Crescent Energy (CRGY) concluded the recent trading session at $15.02, signifying no movement from its prior day's close.
Crescent Energy (CRGY) closed at $15.09 in the latest trading session, marking a -0.98% move from the prior day.
Crescent Energy (CRGY) closed at $15.45 in the latest trading session, marking a -1.21% move from the prior day.
Here is how Crescent Energy (CRGY) and Kodiak Gas Services (KGS) have performed compared to their sector so far this year.
Crescent Energy (CRGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Two oil and gas stocks hit 52-week highs as energy prices popped Friday. The stocks are in buy zones while a medical device stock climbed.